All In MedTech

FDA Clearance Tracker · P190015-S016

TREO® Abdominal Stent-Graft System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 22, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 22, 2024

Approved

Time to decision

65 days

Received Mar 18, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P190015-S016
Device name
TREO® Abdominal Stent-Graft System
Applicant location
Sunrise, FL
Received
Mar 18, 2024
Decided
May 22, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P190015

Device type

Device class
Class III

Every decision under product code MIH

FDA's approval statement

As written in FDA's record.

approval for a manufacturing site Terumo Aortic Glasgow located at Newmains Ave, Inchinnan, Glasgow PA4 9RR, United Kingdom for manufacture of the Delivery System subassembly, loading of the Stent-Graft subassembly onto the Delivery System, and non-sterile packaging of the loaded Delivery System subassemblies of the Bifurcate and Cuff components of the TREO® Abdominal Stent-Graft System

Source documents

Other decisions for Bolton Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.